Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ARQT
DYN
Add up to 3 more stocks
ARQT
Arcutis Biotherapeutics, Inc.
-3.70%
$24.22-0.93Delayed quote: Oct 6, 2026, 10:15 AM EDT
Market Cap
$3.03B
52W Range
$19.30 - $31.77
DYN
Dyne Therapeutics, Inc.
-2.63%
$15.03-0.41Delayed quote: Oct 6, 2026, 10:15 AM EDT
Market Cap
$2.81B
52W Range
$12.77 - $27.31
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 116.16 | N/A |
| Forward P/E | 48.72 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.73 | 4.00 |
| P/S Ratio | 6.53 | N/A |
| P/FCF Ratio | 77.38 | N/A |
| EV/EBITDA | 83.58 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 91.1% | 0.0% |
| Operating Margin | -3.3% | 0.0% |
| Net Margin | 6.2% | 0.0% |
| ROE | 12.9% | -74.0% |
| ROA | 5.8% | -52.3% |
| ROIC | 9.9% | -58.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.92 | 12.02 |
| Quick Ratio | 2.67 | 12.02 |
| Debt/Equity | 0.52 | 0.03 |
| Interest Coverage | -1.01 | -75.61 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.